Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

Share Price is delayed by 15 minutes
Get Live Data
93.50    -1.00 (-1.06%)
Bid:
93.40
Ask:
93.70
Spread: 0.30 (0.321%)
Market Cap: £344.39m
CCR Live PriceLast checked at - London Stock Exchange

Intraday C&C Group Share Chart

Statement re Board Changes

25 Oct 2018 07:01

Board Changes

Dublin, London, 25 October 2018: C&C Group plc (‘C&C’ or the 'Group’), a leading manufacturer, marketer and distributor of branded cider, beer, wine and soft drinks today announces a series of changes to its Board of Directors.

Having overseen the smooth transition to a new Chairman, Richard Holroyd the Senior Non-Executive and Director since 2004 has informed the Board of his wish to step down and leave the Board in the new year. Geoffrey Hemphill a Non-Executive Director since 2017 has also informed of his intention to stand down from the Board to concentrate on other business interests.

On his appointment as Chairman Stewart Gilliland undertook a review of the composition of the Board to ensure that it has the right balance of skills and experience particularly in light of the strategically important acquisition of Matthew Clark and Bibendum.

The conclusion of this review was that the International Division would no longer be represented at the Group Board and the composition of the Board would be best comprised of a Chairman, 3 Executives (CEO, CFO and COO) and a reduced number of Non-Executive Directors.

Accordingly, Joris Brams as an Executive Director will stand down from the Board. Jim Clerkin, Vincent Crowley and Emer Finnan all Non-Executive Directors will remain in role and a search for new Non-Executive Directors with the appropriate skills and experience has commenced.

We are very grateful to Richard, Geoffrey and Joris for the individual contribution each of them has made to the Group’s long-term development.

ENDS

Contacts

C&C Group plc

Stephen Glancey | Group Chief Executive

Jonathan Solesbury | Chief Financial Officer

Joe Thompson | Head of Investor Relations

Tel: +44 7980 844 580

Email: Joe.Thompson@candcgroup.com

FTI Consulting

Mark Kenny/Jonathan Neilan/Paddy Berkery

Tel: +353 1 765 0886

Email: CandCGroup@fticonsulting.com

Novella Communications

Tim Robertson/Toby Andrews

Tel: +44 203 151 7008

Email: TimR@novella-comms.com

About C&C Group plc

C&C Group plc is a premium drinks company which owns, manufactures, markets and distributes branded beer, cider, wine, soft drinks and bottled water. C&C Group brands include: Bulmers the leading Irish cider brand; Tennent’s, the leading Scottish beer brand; Magners the premium international cider brand; as well as a range of super-premium and craft ciders and beers. C&C Group also owns and manufactures Woodchuck, a leading craft cider brand in the United States and manufactures and distributes a number of 3rd party international beer brands in Scotland and Ireland. C&C is also a leading drinks wholesaler in the UK and Ireland, where it operates under the Matthew Clark, Bibendum, Tennent's and C&C Gleeson brands. C&C Group has a minority investment in the Admiral Taverns tenanted pub group, which owns over 850 pubs across England & Wales. C&C Group is headquartered in Dublin with manufacturing operations in Co.Tipperary, Ireland; Glasgow, Scotland; and Vermont, US. C&C Group plc is listed on the Irish and London Stock Exchanges.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181024006006/en/

Copyright Business Wire 2018

Date   Source Headline
18th Jul 20257:00 amRNSTransaction in Own Shares
17th Jul 20257:00 amRNSTransaction in Own Shares
16th Jul 20255:05 pmRNSDirector/PDMR Shareholding
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 20257:00 amRNSResult of AGM
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20254:15 pmRNSHolding(s) in Company
2nd Jul 20258:00 amRNSTotal Voting Rights
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20253:22 pmRNSDirector/PDMR Shareholding
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20256:03 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
16th Jun 20255:00 pmRNSDirector/PDMR Shareholding
16th Jun 202512:00 pmRNSAnnual Report and Notice of AGM
16th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20256:00 pmRNSDirector/PDMR Shareholding
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 202512:45 pmRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSFinal Results
27th May 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.